Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:47 AM
Ignite Modification Date:
2025-12-25 @ 2:47 AM
NCT ID:
NCT03712033
Eligibility Criteria:
Inclusion Criteria:
* Patients who had a minor stroke or TIA in the past year and seen at SPC.
* Systolic hypertension at least 10 mm Hg above target, defined as any of:
1. A definite history of systolic hypertension before stroke as per CHEP (Canadian Hypertension Education Program) guidelines, or
2. Currently receiving antihypertensive medications, or
3. Any two documented SBP above 150 mm Hg (or above 140 mm Hg if diabetic) - either by history, on referral forms, or on an average of blood pressure measurements done during the patient's appointment at SPC
* 18 years or older
* Informed consent from patient or substitute decision-maker
* Able to comprehend medication instructions over the phone in English, or has a caregiver able to do so.
* If patient is unable to directly participate in the Telehealth intervention (e.g. severe aphasia, has English as a second language, modified Rankin Scale score (mRS) \>4, a caregiver or family must be available to participate with the BP monitoring procedures and medication titration).
Exclusion Criteria:
* Patients admitted at long term care facilities or rehabilitation facilities (If admitted at rehabilitation facility, patient must be discharged prior to enrollment in the study)
* Unable to comply with home blood pressure monitoring procedures for any other reason
* Participation in other interventional (i.e., drug or device) clinical trials
* Severe illness or another major illness that would affect ability to attend the study visits
* Dialysis or diagnosis of end stage renal disease
* Secondary hypertension (e.g. hypertension secondary to a known medical condition such as renal artery stenosis, pheochromocytoma, etc.)
* Life expectancy \< 12 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03712033
Study Brief:
Protocol Section:
NCT03712033